Gene Solutions is expanding precision oncology education in Malaysia through its "Beyond Actionable" Academy, an initiative centered on helping clinicians and healthcare stakeholders better understand the latest developments in cancer profiling.
At the Precision Oncology Academy 2026, international experts examined how information from tumour DNA and RNA can support a more detailed view of cancer. The discussions focused on how these molecular signals may help uncover treatment opportunities and shed light on why some therapies stop working as expected.
The program reflects a broader shift in precision oncology from simply identifying actionable findings to interpreting a wider range of tumour biology. That approach can help connect laboratory insights with more informed decisions in real-world oncology care.
By bringing this education effort to Malaysia, Gene Solutions is placing emphasis on knowledge sharing in a fast-moving field where testing technologies and treatment strategies continue to evolve. The academy highlights the growing role of molecular analysis in shaping more tailored cancer management.
